Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News EKF Diagnostics announces Joslin Diabetes Center partnership

EKF Diagnostics announces Joslin Diabetes Center partnership

21st November 2014

EKF Diagnostics has announced a new multi-year collaborative biomarker research partnership with the Joslin Diabetes Center.

The work will support the ongoing clinical and commercial translation of TNFR1 and 2 biomarkers, which can help identify patients with type 1 and 2 diabetes who are at an increased risk of developing end-stage renal disease up to ten years in advance.

EKF will gain access to certain clinical and research expertise at Joslin to further develop a TNFR biomarker test, with studies to be carried out to support the clinical utility of TNFR 1 and 2 assays as biomarkers in diabetic kidney disease.

This marks the continuation of a long-standing relationship between EKF and Joslin that dates back to 2012.

Julian Baines, chief executive officer of EKF Diagnostics, said: "Through our excellent relationship with the Joslin Center, we are focused on bringing this test into clinical practice, leading to improved outcomes for diabetic patients at risk of progressive kidney disease."

This comes after the firm recently announced that it will be partnering with Massachusetts General Hospital to create new PointMan assays for cancer diagnosis.ADNFCR-8000103-ID-801761746-ADNFCR

We currently have 10 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.